Prior studies showed an association between greater CD8+ TEMRAs and worse cognitive function in people with probable AD, and greater CD8+ TEMRAs in cognitively healthy people with preclinical AD, defined by cognitive scores, CSF Aβ and tau levels, MRI, and Aβ PET imaging [5, 6]. Here, MAPT is linked to Alzheimer disease.